Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)
This study has been completed.
First Posted: August 22, 2011
Last Update Posted: February 6, 2014
Information provided by (Responsible Party):